Firestone Capital Management Adamis Pharmaceuticals Corp Transaction History

Firestone Capital Management

  • $389 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$0.57 - $1.23 $2,963 - $6,396
-5,200 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$0.51 - $1.26 $2,346 - $5,796
4,600 Added 766.67%
5,200 $4,000
Q4 2019

Feb 10, 2020
BUY
$0.51 - $1.26 $306 - $756
600 New
600 $4,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Firestone Capital Management Portfolio

Follow Firestone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Firestone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Firestone Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email